Transcutaneous should replace arterial PCO2 monitoring during nocturnal noninvasive ventilation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00000433

Enrollment

Registered

2010-06-07

Start date

2008-08-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J00-J99

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Cardio-respiratory stable patients with a pH >7,30 will be included. Patients will be studied during a clinical check up visit in the sleep unit of the Department of Pneumology, Univeristy Hospital Freiburg. Inclusion criteria are independent from the underlying disease causing ventilatory failure.

Exclusion criteria

Exclusion criteria: Patients with evidence of acute respiratory failure (e.g. worsening symptoms during the last two weeks, a breathing frequency (fb) > 30/min, a pH 35 kg/m2 will be excluded.

Design outcomes

Primary

Measure	Time frame
Difference of technical drifts between all three transcutaneous PCO2-monitors (SenTec DM, TCM4-TINA and TOSCA500) after eight hours of nighttime monitoring.	—

Secondary

Measure	Time frame
Method comparison and correlation between transcutaneous and arterial pressures of carbon dioxide.	—

Countries

Germany

Contacts

Public ContactJan Hendrik Storre

Universitätsklinik Freiburg Innere Medizin V - Pneumologie

jan.storre@uniklinik-freiburg.de0049 761 270 3401

Outcome results